04/15/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:58 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/27/2024
7:02 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:57 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:07 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:10 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:13 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:08 AM | ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/09/2024
7:35 AM | ACADIA Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
4:05 PM | ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/08/2024
4:09 PM | ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
8:55 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:00 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
6:37 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:46 AM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023
4:32 PM | ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:11 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:21 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
4:30 PM | ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
9:00 PM | ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
8:59 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
5:31 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
12:06 PM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023
6:31 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
10:15 AM | ACADIA Pharmaceuticals (Subject)
Schneyer Mark C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
5:00 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:01 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
10:33 AM | ACADIA Pharmaceuticals (Subject)
DAVIS STEPHEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
7:27 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
9:42 AM | ACADIA Pharmaceuticals (Subject)
DAVIS STEPHEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:38 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Hard Truth About Investing For Retirement (Ad) Here’s the cold, hard truth about investing:
The more capital you have, the more risk averse you can afford to be.
But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive.
In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! |
06/15/2023
10:36 AM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
4:14 PM | ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
7:48 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
1:34 PM | ACADIA Pharmaceuticals (Subject)
Brege Laura (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
8:43 PM | ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:46 PM | ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:34 PM | ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:38 PM | ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:39 PM | ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
8:42 PM | ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:09 PM | 667, L.P. (Reporting)
ACADIA Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:11 PM | ACADIA Pharmaceuticals (Subject)
BAKER BROS. ADVISORS LP (Filed by)
| Form SC 13D/A | |
05/19/2023
5:54 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
5:43 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
5:48 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2023
4:29 PM | ACADIA Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2023
8:13 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
8:14 PM | ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
8:15 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
8:16 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
8:17 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:02 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:04 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:06 PM | ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
